Syneron Bio
Develops intelligent platform-driven macrocyclic peptide drug discovery
$150MSeries B
Role not disclosedQV
Qiming Venture Partners
Activity from announced rounds
Activity in this selectionAI
- Rounds participated in
- 3
- Confirmed lead rounds
- — 3 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $309M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionStairMed
Develops minimally invasive implantable brain-machine interfaces (BMI) for neurological diseases
CN¥500MStrategic
Role not disclosedShengShu Technology
Develops multimodal foundation models for video generation and AI productivity
CN¥600MSeries A
Role not disclosed